Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

Share Price is delayed by 15 minutes
Get Live Data
171.75    0.25 (0.15%)
Bid:
171.80
Ask:
171.85
Spread: 0.05 (0.029%)
Market Cap: £7.78b
CNA Live PriceLast checked at - London Stock Exchange

Intraday Centrica Share Chart

Transaction in Own Shares

9 Dec 2024 07:00

RNS Number : 2249P
Centrica PLC
09 December 2024
Β 

Transactions in own shares

Β 

Centrica plc

9 December 2024

Β 

Centrica plc announces that it purchased on 6 December 2024 (through Goldman Sachs International) 500,000 Centrica plc ordinary shares of 6 14/81 pence each at a price of 130.3300 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the Company's buyback programme announced on 8 August 2024 and in accordance with the non-discretionary share repurchase agreement entered into with Goldman Sachs International.

Β 

Since 8 August 2024, Centrica has purchased 116,022,599 ordinary shares at a cost (excluding dealing and associated costs) of Β£140,415,579.45.

Β 

Following the above purchase, Centrica plc holds 459,676,660 ordinary shares in treasury, and has 5,108,430,554 ordinary shares in issue (excluding treasury shares).

Β 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by Goldman Sachs International is set outbelow.

Β 

Transaction details: Centrica plc ordinary shares of 6 14/81 pence each

Β 

Issuer name:

Centrica plc

ISIN:

GB00B033F229

Intermediary name:

Goldman Sachs International

Intermediary Code:

GSILGB2XXXX

Currency:

GBP

Β 

Aggregated information

Date of purchase:

6 December 2024

Number of ordinary shares purchased:

500,000

Highest price paid:

131.2500p

Lowest price paid:

129.4500p

Volume weighted average price paid per share:

130.3300p

Β 

Disaggregated information

Β 

The table attached contains detailed information of the individual trades made by Goldman Sachs International, as part of the buyback programme.

Β 

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/2249P_1-2024-12-6.pdf

Β 

END

Β 

Enquiries:

Investors and Analysts

T: 01753 494900

E: ir@centrica.com

Β 

Β 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSDZMGZNVRGDZM
Date   Source Headline
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20255:45 pmRNSTotal Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20254:00 pmRNSDirector/PDMR Shareholding
28th Mar 20254:00 pmRNSDirector/PDMR Shareholding
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20254:00 pmRNSNotice of AGM
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20253:00 pmRNSDirector/PDMR Shareholding
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20255:45 pmRNSHolding(s) in Company
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20253:00 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20254:30 pmRNSHolding(s) in Company
20th Mar 20253:45 pmRNSHolding(s) in Company
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20252:32 pmRNSAnnual Financial Report 2024
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20256:15 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20256:00 pmRNSTotal Voting Rights
3rd Mar 20257:01 amRNSUpdate on Share Buyback Extension
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 202512:30 pmRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20254:45 pmRNSCancellation of treasury shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:02 amRNSCentrica concludes triennial pension scheme review
20th Feb 20257:02 amRNSCentrica signs Brazilian LNG supply agreement
20th Feb 20257:02 amRNSCentrica expansion in the Irish power market
20th Feb 20257:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.